The role of RAAS blockade in kidney transplantation
Crossref DOI link: https://doi.org/10.1038/nrneph.2015.201
Published Online: 2015-12-14
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Toto, Robert D.
Text and Data Mining valid from 2015-12-14
Article History
First Online: 14 December 2015
Competing interests
: R.D.T has received honoraria for consulting and advisory board activities from Amgen, Boehringer–Ingelheim, Celgene, Relypsa, and ZS Pharmaceuticals.